Tuesday, March 18, 2025 | 10:08 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Covaxin booster neutralises both Omicron and Delta variants: Bharat Biotech

'More than 90% of all individuals boosted with Covaxin showed neutralising antibodies,' says Hyderabad-based Bharat Biotech

covaxin, bharat biotech, coronavirus vaccine, covid-19, vaccination
Premium

The company said that Covaxin (BBV152) booster dose generated ‘robust neutralising antibody responses’ against both Omicro (B.1.529) and Delta (B.1.617.2) using a live virus neutralisation assay (test)

Sohini Das Mumbai
Booster shot of Covaxin neutralises both Omicron and Delta variants of Sars-CoV-2 virus, Bharat Biotech said on Wednesday.

The company said that Covaxin (BBV152) booster dose generated ‘robust neutralising antibody responses’ against both Omicro (B.1.529) and Delta (B.1.617.2) using a live virus neutralisation assay (test). It added that 100 percent of the test serum samples showed neutralisation of the Delta variant, and more than 90 percent of the samples showed neutralisation of the Omicron variant.

The company today announced results from a study conducted at Emory University demonstrating that sera from subjects who received a booster dose of Covaxin (BBV152)

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in